AstraZeneca To Pay $520M In Seroquel Off-Label Case
The company disclosed the settlement in its third-quarter results released on Thursday. According to the report, AstraZeneca reached an agreement in principle with the U.S. attorney to resolve the investigation in September. The deal is subject to the finalization of implementation agreements, the company said.
A spokesman for AstraZeneca said he...
To view the full article, register now.